Brain-Heart Interactions in Traumatic Brain Injury

Ayman El-Menyar, Abhishek Goyal, Rifat - Latifi, Hassan Al-Thani, William Frishman

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

The cardiovascular manifestations associated with nontraumatic head disorders are commonly known. Similar manifestations have been reported in patients with traumatic brain injury (TBI); however, the underlying mechanisms and impact on the patient's clinical outcomes are not well explored. The neurocardiac axis theory and neurogenic stunned myocardium phenomenon could partly explain the brain-heart link and interactions and can thus pave the way to a better understanding and management of TBI. Several observational retrospective studies have shown a promising role for beta-adrenergic blockers in patients with TBI in reducing the overall TBI-related mortality. However, several questions remain to be answered in clinical randomized-controlled trials, including population selection, beta blocker type, dosage, timing, and duration of therapy, while maintaining the optimal mean arterial pressure and cerebral perfusion pressure in patients with TBI.

Original languageEnglish (US)
Pages (from-to)279-288
Number of pages10
JournalCardiology in Review
Volume25
Issue number6
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Brain
Cerebrovascular Circulation
Myocardial Stunning
Adrenergic beta-Antagonists
Observational Studies
Arterial Pressure
Randomized Controlled Trials
Retrospective Studies
Head
Traumatic Brain Injury
Mortality
Population
Therapeutics

Keywords

  • beta adrenergic blockers
  • biomarkers
  • brain injury
  • catecholamines
  • myocardial dysfunction
  • neurocardiac axis
  • neurogenic stunned myocardium
  • trauma
  • troponins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Brain-Heart Interactions in Traumatic Brain Injury. / El-Menyar, Ayman; Goyal, Abhishek; Latifi, Rifat -; Al-Thani, Hassan; Frishman, William.

In: Cardiology in Review, Vol. 25, No. 6, 01.01.2017, p. 279-288.

Research output: Contribution to journalReview article

El-Menyar, A, Goyal, A, Latifi, R, Al-Thani, H & Frishman, W 2017, 'Brain-Heart Interactions in Traumatic Brain Injury', Cardiology in Review, vol. 25, no. 6, pp. 279-288. https://doi.org/10.1097/CRD.0000000000000167
El-Menyar, Ayman ; Goyal, Abhishek ; Latifi, Rifat - ; Al-Thani, Hassan ; Frishman, William. / Brain-Heart Interactions in Traumatic Brain Injury. In: Cardiology in Review. 2017 ; Vol. 25, No. 6. pp. 279-288.
@article{6176494e1fb74f7e81b7944e6c4c3236,
title = "Brain-Heart Interactions in Traumatic Brain Injury",
abstract = "The cardiovascular manifestations associated with nontraumatic head disorders are commonly known. Similar manifestations have been reported in patients with traumatic brain injury (TBI); however, the underlying mechanisms and impact on the patient's clinical outcomes are not well explored. The neurocardiac axis theory and neurogenic stunned myocardium phenomenon could partly explain the brain-heart link and interactions and can thus pave the way to a better understanding and management of TBI. Several observational retrospective studies have shown a promising role for beta-adrenergic blockers in patients with TBI in reducing the overall TBI-related mortality. However, several questions remain to be answered in clinical randomized-controlled trials, including population selection, beta blocker type, dosage, timing, and duration of therapy, while maintaining the optimal mean arterial pressure and cerebral perfusion pressure in patients with TBI.",
keywords = "beta adrenergic blockers, biomarkers, brain injury, catecholamines, myocardial dysfunction, neurocardiac axis, neurogenic stunned myocardium, trauma, troponins",
author = "Ayman El-Menyar and Abhishek Goyal and Latifi, {Rifat -} and Hassan Al-Thani and William Frishman",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/CRD.0000000000000167",
language = "English (US)",
volume = "25",
pages = "279--288",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Brain-Heart Interactions in Traumatic Brain Injury

AU - El-Menyar, Ayman

AU - Goyal, Abhishek

AU - Latifi, Rifat -

AU - Al-Thani, Hassan

AU - Frishman, William

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The cardiovascular manifestations associated with nontraumatic head disorders are commonly known. Similar manifestations have been reported in patients with traumatic brain injury (TBI); however, the underlying mechanisms and impact on the patient's clinical outcomes are not well explored. The neurocardiac axis theory and neurogenic stunned myocardium phenomenon could partly explain the brain-heart link and interactions and can thus pave the way to a better understanding and management of TBI. Several observational retrospective studies have shown a promising role for beta-adrenergic blockers in patients with TBI in reducing the overall TBI-related mortality. However, several questions remain to be answered in clinical randomized-controlled trials, including population selection, beta blocker type, dosage, timing, and duration of therapy, while maintaining the optimal mean arterial pressure and cerebral perfusion pressure in patients with TBI.

AB - The cardiovascular manifestations associated with nontraumatic head disorders are commonly known. Similar manifestations have been reported in patients with traumatic brain injury (TBI); however, the underlying mechanisms and impact on the patient's clinical outcomes are not well explored. The neurocardiac axis theory and neurogenic stunned myocardium phenomenon could partly explain the brain-heart link and interactions and can thus pave the way to a better understanding and management of TBI. Several observational retrospective studies have shown a promising role for beta-adrenergic blockers in patients with TBI in reducing the overall TBI-related mortality. However, several questions remain to be answered in clinical randomized-controlled trials, including population selection, beta blocker type, dosage, timing, and duration of therapy, while maintaining the optimal mean arterial pressure and cerebral perfusion pressure in patients with TBI.

KW - beta adrenergic blockers

KW - biomarkers

KW - brain injury

KW - catecholamines

KW - myocardial dysfunction

KW - neurocardiac axis

KW - neurogenic stunned myocardium

KW - trauma

KW - troponins

UR - http://www.scopus.com/inward/record.url?scp=85040816320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040816320&partnerID=8YFLogxK

U2 - 10.1097/CRD.0000000000000167

DO - 10.1097/CRD.0000000000000167

M3 - Review article

VL - 25

SP - 279

EP - 288

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 6

ER -